Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Dogru

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Acta Gastro-Enterologica Belgica|December 15, 2020
Microvesicular steatosis: a missed item in the management of nonalcoholic fatty liver disease?G Celebi, A F Cicek, H Gurel, et al.
European Review for Medical and Pharmacological Sciences|November 11, 2016
Plasma pentraxin-3 is associated with endothelial dysfunction in non-alcoholic fatty liver diseaseH Gurel, H Genc, G Celebi, et al.
Journal of Human Hypertension|November 11, 2006
Plasma visfatin levels in young male patients with uncomplicated and newly diagnosed hypertensionT Dogru, A Sonmez, I Tasci, et al.
Haematologia|March 4, 2003
Changes in immunological recovery in patients who received post-transplant G-CSF or GM-CSF after autologous peripheral blood stem cell transplantation (PBSCT)F Arpaci, T Dogru, B Ozturk, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 25, 2007
Plasma apelin is lower in patients with elevated LDL-cholesterolI Tasci, T Dogru, I Naharci, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 24, 2005
Soluble CD40 ligand levels in patients with hypertensionAlper Sonmez, T Dogru, M I Yilmaz, et al.
European Review for Medical and Pharmacological Sciences|September 26, 2023
The relationship of circulating MOTS-c level with liver fibrosis and metabolic components in patients with metabolic dysfunction-associated fatty liver diseaseA Kirik, T Dogru, B Yanik, et al.
International Journal of Clinical Practice|August 31, 2006
The plasma levels of soluble P-selectin in subjects with prediabetesT Dogru, I Tasci, A Sonmez, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Acta Gastro-Enterologica Belgica|December 15, 2020
Microvesicular steatosis: a missed item in the management of nonalcoholic fatty liver disease?G Celebi, A F Cicek, H Gurel, et al.
European Review for Medical and Pharmacological Sciences|November 11, 2016
Plasma pentraxin-3 is associated with endothelial dysfunction in non-alcoholic fatty liver diseaseH Gurel, H Genc, G Celebi, et al.
Journal of Human Hypertension|November 11, 2006
Plasma visfatin levels in young male patients with uncomplicated and newly diagnosed hypertensionT Dogru, A Sonmez, I Tasci, et al.
Haematologia|March 4, 2003
Changes in immunological recovery in patients who received post-transplant G-CSF or GM-CSF after autologous peripheral blood stem cell transplantation (PBSCT)F Arpaci, T Dogru, B Ozturk, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 25, 2007
Plasma apelin is lower in patients with elevated LDL-cholesterolI Tasci, T Dogru, I Naharci, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 24, 2005
Soluble CD40 ligand levels in patients with hypertensionAlper Sonmez, T Dogru, M I Yilmaz, et al.
European Review for Medical and Pharmacological Sciences|September 26, 2023
The relationship of circulating MOTS-c level with liver fibrosis and metabolic components in patients with metabolic dysfunction-associated fatty liver diseaseA Kirik, T Dogru, B Yanik, et al.
International Journal of Clinical Practice|August 31, 2006
The plasma levels of soluble P-selectin in subjects with prediabetesT Dogru, I Tasci, A Sonmez, et al.
Pageof 2